Pages that link to "Q37612122"
Jump to navigation
Jump to search
The following pages link to Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis (Q37612122):
Displaying 50 items.
- Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway (Q26800894) (← links)
- Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. (Q30366569) (← links)
- Inflammation in nonalcoholic steatohepatitis (Q30453231) (← links)
- Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation (Q33755829) (← links)
- Non-alcoholic fatty liver disease: An expanded review (Q33789868) (← links)
- GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy (Q34034795) (← links)
- A simple index of lipid overaccumulation is a good marker of liver steatosis (Q34134206) (← links)
- Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation (Q34449332) (← links)
- Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. (Q34750698) (← links)
- Autophagy in nonalcoholic steatohepatitis (Q35014344) (← links)
- Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease (Q35016078) (← links)
- Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease (Q35055531) (← links)
- Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease (Q35183888) (← links)
- Glitazones for human nonalcoholic steatohepatitis (Q35191067) (← links)
- Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly (Q35209849) (← links)
- Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis (Q35643797) (← links)
- Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets (Q35668745) (← links)
- Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver (Q35958436) (← links)
- Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity (Q36076151) (← links)
- FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy (Q36082328) (← links)
- Hepatitis C virus infection and nonalcoholic steatohepatitis (Q36179898) (← links)
- An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). (Q36328050) (← links)
- Electron Therapy Attenuated Elevated Alanine Aminotransferase and Oxidative Stress Values in Type 2 Diabetes-Induced Nonalcoholic Steatohepatitis of Rats (Q36528728) (← links)
- The relationship between the activates of antioxidant enzymes in red blood cells and body mass index in Iranian type 2 diabetes and healthy subjects (Q36635092) (← links)
- Improvement of liquid fructose-induced adipose tissue insulin resistance by ginger treatment in rats is associated with suppression of adipose macrophage-related proinflammatory cytokines (Q36676781) (← links)
- Lipoic Acid prevents the changes of intracellular lipid partitioning by free Fatty Acid (Q36715146) (← links)
- Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury (Q37061460) (← links)
- Identification of Metabolic risk phenotypes predisposing to Non-Alcoholic Fatty Liver Disease in a Pakistani Cohort (Q37723542) (← links)
- The importance of fatty liver disease in clinical practice (Q37766943) (← links)
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites (Q37777696) (← links)
- Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment (Q37847587) (← links)
- Nonalcoholic fatty liver disease: current issues and novel treatment approaches (Q38074898) (← links)
- Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? (Q38090585) (← links)
- Steatosis in the liver. (Q38165140) (← links)
- A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference (Q39008520) (← links)
- ER stress and autophagy dysfunction contribute to fatty liver in diabetic mice (Q39716920) (← links)
- The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver (Q39860522) (← links)
- Function of Autophagy in Nonalcoholic Fatty Liver Disease (Q40408431) (← links)
- Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. (Q41430210) (← links)
- Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice (Q44798679) (← links)
- Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis (Q44931170) (← links)
- Insulin resistance: a risk marker for disease and disability in the older person (Q45330314) (← links)
- Fatty liver disease: the hepatic manifestation of metabolic syndrome (Q46193548) (← links)
- Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). (Q47747733) (← links)
- Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan (Q47849653) (← links)
- Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. (Q51372025) (← links)
- Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans. (Q51758740) (← links)
- Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. (Q53113517) (← links)
- Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway. (Q54468632) (← links)
- Plasma concentrations of zonulin are elevated in obese men with fatty liver disease. (Q54974371) (← links)